The PDT activity of free and pegylated pheophorbide a against an amelanotic melanoma transplanted in C57/BL6 mice

Investigational New Drugs

Volumn 31, Issue 1, 2013, Pages 192-199

  Rapozzi, Valentina ^a   Zorzet, Sonia ^b   Zacchigna, Marina ^b   Drioli, Sara ^b   Xodo, Luigi E ^a  

^a Section of Oncology and Molecular Pathology   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Melanoma; Mice; mPEG conjugation; Pheophorbide a; Photodynamic therapy

Indexed keywords

MACROGOL DERIVATIVE; MONOMETHOXYPOLYETHYLENE GLYCOL; PHEOPHORBIDE; PHEOPHORBIDE ALPHA; UNCLASSIFIED DRUG;

AMELANOTIC MELANOMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG TOXICITY; FEMALE; IN VIVO STUDY; LASER; MOUSE; NONHUMAN; PHOTOACTIVATION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SURVIVAL TIME; TREATMENT RESPONSE;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; CHLOROPHYLL; FEMALE; LIGHT; MELANOMA, AMELANOTIC; MICE; MICE, INBRED C57BL; PHOTOCHEMOTHERAPY; POLYETHYLENE GLYCOLS; RADIATION-SENSITIZING AGENTS;

EID: 84873080333     PISSN: 01676997     EISSN: 15730646     Source Type: Journal    
DOI: 10.1007/s10637-012-9844-4     Document Type: Article

References (51)

1. Dolmans DE, Fukimura D, Jain RK (2003) Photodynamic therapy for cancer. Nat Rev Cancer 3:380-387
2. Dougherty TJ, Gomer CJ, Henderson BW et al (1998) Photodynamic therapy. J Natl Cancer Inst 90:889-905
3. Pervaiz S (2001) Reactive oxygen-dependent production of novel photochemotherapeutic agents. FASEB J 15:612-617
4. Juarranz A, Jaén P, Sanz-Rodríguez F et al (2008) Photodynamic therapy of cancer. Basic principles and applications. Clin Transl Oncol 10:148-154
5. Detty MR, Gibson SL, Wagner SJ (2004) Current clinical and preclinical photosensitizers for use in photodynamic therapy. J Med Chem 47:3897-3915
6. Schuitmaker JJ, Baas P, van Leengoed HL et al (1996) Photodynamic therapy: a promising new modality for the treatment of cancer. J Photochem Photobiol B 34:3-12
7. Agostinis P, Berg K, Cengel KA et al (2011) Photodynamic therapy of cancer: an update. CA Cancer J Clin 61:250-281
8. Derycke AS, Kamuhabwa A, Gijsens A et al (2004) Transferrin-conjugated liposome targeting of photosensitizer AlPcS4 to rat bladder carcinoma cells. J Natl Cancer Inst 96:1620-1630
9. Master AM, Qi Y, Oleinick NL et al (2011) EGFR-mediated intracellular delivery of Pc 4 nanoformulation for targeted photodynamic therapy of cancer: in vitro studies. Nanomedicine. doi: 10.1016/j.nano.2011.09.012
10. Abu-Yousif AO, Moor AC, Zheng X et al (2012) Epidermal growth factor receptor-targeted photosensitizer selectively inhibits EGFR signaling and induces targeted phototoxicity in ovarian cancer cells. Cancer Lett. doi: 10.1016/j.canlet.2012.01.014
11. Giuntini F, Alonso CM, Boyle RW (2011) Synthetic approaches for the conjugation of porphyrin and related macrocycles to peptides and proteins. Photochem Photobiol Sci 10:759-791
12. Srivatsan A, Ethirajan M, Pandey SK et al (2011) Conjugation of cRGD peptide to chlorophyll a based photosensitizer (HPPH) alters its pharmacokinetics with enhanced tumor-imaging and photosensitizing (PDT) efficacy. Mol Pharm 8:1186-1197
13. Bhatti M, Yahioglu G, Milgrom LR et al (2008) Targeted photodynamic therapy with multiply-loaded recombinant antibody fragments. Int J Cancer 122:1155-1163
14. Van Dongen GA, Visser GW, Vrouenraets MB (2004) Photosensitizer-antibody conjugates for detection and therapy of cancer. Adv Drug Deliv Rev 56:31-52
15. Gupta S, Dwarakanath BS, Chaudhury NK et al (2011) In vitro and in vivo targeted delivery of photosensitizers to the tumor cells for enhanced photodynamic effects. J Cancer Res Ther 7:314-324
16. Shieh YA, Yang SJ, Wei MF et al (2010) Aptamer-based tumor-targeted drug delivery for photodynamic therapy. ACS Nano 4:1433-1442
17. Zheng X, Pandey RK (2008) Porphyrin-carbohydrate conjugates: impact of carbohydrate moieties in photodynamic therapy (PDT). Anticancer Agents Med Chem 8:241-268
18. Di Stasio B, Frochot C, Dumas D et al (2005) The 2- aminoglucosamide motif improves cellular uptake and photodynamic activity of tetraphenylporphyrin. Eur J Med Chem 40:1111-1122
19. Gravier J, Schneider R, Frochot C et al (2008) Improvement of metatetra(hydroxyphenyl)chlorin-like photosensitizer selectivity with folate-based targeted delivery. Synthesis and in vivo delivery studies. J Med Chem 51:3867-3877
20. Hamblin MR, Miller JL, Rizvi I et al (2001) Pegylation of a chlorin(e6) polymer conjugate increases tumor targeting of photosensitizer. Cancer Res 61:7155-7162
21. Hamblin MR, Miller JL, Rizvi I et al (2003) Pegylation of charged polymer photosensitizer conjugates: effects on photodynamic efficacy. Br J Cancer 89:937-943
22. Chouikrat R, Seve A, Vanderesse R et al (2012) Non polymeric nanoparticles for photodynamic therapy applications: recent developments. Curr Med Chem 19:781-792
23. Wieder ME, Hone DC, Cook MJ et al (2006) Intracellular photodynamic therapy with photosensitizer-nanoparticle conjugates: cancer therapy using a 'Trojan horse'. Photochem Photobiol Sci 5:727-734
24. Stuchinskaya T, Moreno M, Cook MJ et al (2011) Targeted photodynamic therapy of breast cancer cells using antibody-phthalocyanine-gold nanoparticle conjugates. Photochem Photobiol Sci 10:822-831
25. Couleaud P, Morosini V, Frochot C et al (2010) Silica-based nanoparticles for photodynamic therapy applications. Nanoscale 2:1083-1095
26. Zhu Z, Tang Z, Phillips JA et al (2008) Regulation of singlet oxygen generation using single-walled carbon nanotubes. J Am Chem Soc 130:10856-10857
27. Huang P, Lin J, Yang D et al (2011) Photosensitizer-loaded dendrimer-modified multi-walled carbon nanotubes for photodynamic therapy. J Control Release 152(Suppl 1):e33-e34
28. Sortino S, Mazzaglia A, Monsù Scolaro L et al (2006) Nanoparticles of cationic amphiphilic cyclodextrins entangling anionic porphyrins as a "carrier-sensitizer" system in photodynamic cancer therapy. Biomaterials 27:4256-4265
29. McCarthy JR, Perez JM, Bruckner C et al (2005) Polymeric nanoparticle preparation that eradicates tumors. Nano Lett 5:2552-2556
30. Takamiya K, Tsuchiya T, Ohta H (2000) Degradation pathways of chlorophyll: what has gene cloning revealed? Trends Plan Sci 5:426-431
31. Rapozzi V, Zacchigna M, Biffi S et al (2010) Conjugated PDT drug. Photosensitizing activity and tissue distribution of PEGylated pheophorbide a. Cancer Biol Ther 10:1-12
32. Taub AF (2008) Photodynamic therapy in dermatology. In: Hamblin MR, Mroz P (eds) Advances in photodynamic therapy: basic, translational and clinical, Artech House, Boston, pp 419-442
33. Soncin M, Busetti A, Reddi E et al (1997) Pharmacokinetic and phototherapeutic properties of axially substitued Si(IV)-tetradibenzobarreleno- octabutoxyphtalocyanines. J Photochem Photobiol B 40:163-167
34. Fabris C, Vicente MGH, Hao E et al (2007) Tumour-localizing and-photosensitizing properties of meso-tetra(4-nido-carboranylphenyl)porphyrin. J Photochem Photobiol B: Biol 89:131-136
35. Camerin M, Magaraggia M, Soncin M et al (2010) The in vivo efficacy of phthalocyanine-nanoparticle conjugates for the photodynamic therapy of amelanotic melanoma. Eur J Cancer 46:1910-1918
36. Nelson JS, McCullough JL, Berns MW (1988) Photodynamic therapy of human- malignant melanoma xenografts in at hymic nude mice. J Natl Cancer Inst 80:56-60
37. Campaner P, Drioli S, Bonora GM (2006) Synthesis of selectively end-modified high-molecular weight polyethylenglycol. Lett Org Chem 10:773-779
38. Röeder B, Hanke TH, Oelckers ST et al (2000) Photophysical properties of pheophorbide a in solution and in a model membrane systems. J Porphyr Phtalocyanines 4:37-44
39. Sternberg ED, Dolphin D, Bruckner C (1998) Porphyrin based photosensitizers for use in photodynamic therapy. Tetrahedron 54:4151-4202
40. Xodo LE, Rapozzi V, Zacchigna M et al (2012) The chlorophyll catabolite pheophorbide a as a photosensitizer for the photodynamic therapy. Curr Med Chem 19:799-807
41. Tang PM, Zhang DM, Xuan NH et al (2009) Photodynamic therapy ninhibits p-glycoprotein mediated multidrug resistanve via JNK activation in human hepatocellular carcinoma using the photosensitizer pheophorbide a. Mol Cancer 8:56-67
42. Rapozzi V, Miculan M, Xodo LE (2009) Evidence that photoactivated pheophorbide a causes in human cancer cells a photodynamic effect involving lipid peroxidation. Cancer Biol Ther 8:1318-1327
43. Hajri A, Wack S, Meyer C et al (2002) In vitro and in vivo efficacy of Photofrin and Pheophorbide a, a bacteriochlorin, in photodynamic therapy of colonic cancer cells. Photochem Photobiol 75:140-148
44. Hoi SW, Wong HM, Chan JY et al (2011) Photodynamic therapy of pheophorbide a inhibits the proliferation of human breast tumour via both caspase-dependent and -independent apoptotic pathways in in vitro and in vivo models. Phytother Res. doi: 10.1002/ptr.3607
45. Knop K, Hoogenboom R, Fischer D, Schubert US (2010) Poly(ethylene glycol) in drug delivery:pros and cons as well as potential alternatives. Angew Chem Int Ed Engl 49:6288-6308
46. Rapozzi V, Umezawa K, Xodo LE (2011) Role of NF-kB/Snail/RKIP loop in the response of tumor cells to photodynamic therapy. Lasers Surg Med 43:575-585
47. Torres M (2003) Mitogen-activated protein kinase pathways in redox signaling. Front Biosci 8:d369-d391
48. Landeer HM, Milbank AJ, Tauras JM et al (1996) Redox regulation of cell signaling. Nature 381:380-381
49. Chan WH (2011) Photodynamic therapy induces apoptotic pathway involving calcium, nitric oxide, p53, p21-activated kinase 2, and c-jun N-terminal kinase and inactivates survival signal in human umbilical vein endothelial cells. Int J Mol Sci 12:1041-1059
50. Berlett BS, Stadtman ER (1997) Protein oxidation in aging, disease and oxidative stress. J Biol Chem 272:20313-20316
51. Wiegell SR, Fabricius S, Stender IM et al (2011) A randomized, multicentre study of directed daylight exposure times of 1 vs. 2 h in daylight-mediated photodynamic therapy with methyl aminolaevulinate in patients with multiple thin actinic keratoses of the face and scalp. Br J Dermatol 164:1083-1090